A coronavirus vaccine being developed by the University of Oxford and AstraZeneca should be available globally "at cost price" by year end, the firm's director general said Tuesday.
/https://s2.mihaaru.com/photos/2020/07/22/280707_3_f2fd6c2bd83cee067879fbb26910a926397e2bc1_large.jpg)
a general view is pictured of the offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire on July 21, 2020. (Photo by Paul ELLIS / AFP)
2020-07-22 11:23:13
A coronavirus vaccine being developed by the University of Oxford and AstraZeneca should be available globally "at cost price" by year end, the firm's director general said Tuesday.
"Our objective is to bring the vaccine to everybody, (and) equally to do so on a not-for-profit basis so we shall be providing the vaccine at cost price," Pascal Soriot told RTL radio.
Copyright © 2025 The Edition
/https://s1.mihaaru.com/photos/2025/03/03/412239_3_0d44335ad3c46bcc013565bc8f2b060cc771eb05_large.jpg)
/https://cdn.mihaaru.com/photos/2024/11/18/405822_3_42991b287152e728fb9dc1a34b047616b3c170b2_large.jpg)
/https://s2.mihaaru.com/photos/2025/02/22/411540_3_4a48676775adcce55fa65b35db06d54c556c2d45_large.jpg)
/https://cdn.mihaaru.com/photos/2025/01/20/409609_3_8619638b962d13f7368c9bfe329a353eeeb47616_large.jpg)